Impetigo – Ozenoxacin Phase lll Trial – Medical News Today

Participants will receive either ozenoxacin 1% cream or placebo. Ozenoxacin belongs to a new generation of non-fluorinated quinolone antibacterial agent. Ozenoxacin is currently undergoing clinical development, formulated as a topical 1% cream …